Compare RPC & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RPC | TLRY |
|---|---|---|
| Founded | 1992 | N/A |
| Country | United States | Canada |
| Employees | 326 | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 911.9M | 688.9M |
| IPO Year | N/A | 2018 |
| Metric | RPC | TLRY |
|---|---|---|
| Price | $8.33 | $5.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $11.00 | ★ $72.33 |
| AVG Volume (30 Days) | 330.1K | ★ 3.5M |
| Earning Date | 05-07-2026 | 04-01-2026 |
| Dividend Yield | ★ 1.96% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.82 | $8.79 |
| Revenue Next Year | $15.80 | $19.98 |
| P/E Ratio | $53.06 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.79 | $0.36 |
| 52 Week High | $9.32 | $15.70 |
| Indicator | RPC | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 52.60 | 42.97 |
| Support Level | $8.02 | $5.09 |
| Resistance Level | $8.88 | $7.01 |
| Average True Range (ATR) | 0.25 | 0.21 |
| MACD | -0.03 | 0.06 |
| Stochastic Oscillator | 33.77 | 68.95 |
Ridgepost Capital Inc, formelrly P10 Inc is a player in the alternative asset management sector, specializing in multi-asset class private market solutions. It offers a range of investment solutions, including specialized funds, separate accounts, secondary investments, direct investments, and co-investments across various asset classes and geographies. These solutions cater to diverse investor needs within the private markets, aiming to deliver superior risk-adjusted returns. With a focus on middle and lower-middle markets, the company's portfolio includes Private Equity, Venture Capital, Impact Investing, and Private Credit. Its Revenue mainly comes from recurring management and advisory fees earned on committed capital, typically locked up for ten to fifteen years.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.